The frontlines of longevity and AI

Where you start to take control of aging

Recent breakthroughs in understanding the biology of aging are changing how we think about extending healthy longevity. At the same time, groundbreaking progress in machine learning is enabling us to extract actionable insights from complex longevity-related data.

By bringing together the latest advances in longevity and data science we can now meaningfully impact both healthspan and lifespan.
JOIN THE WAITLIST
Header image

Mission

To enable tangible improvements in longevity by introducing the concept of personalized precision longevity management through a technology platform that uses data science to unlock the power of the latest scientific longevity interventions.

Data driven. Science based. Personalized. Impactful.
determined woman gazing upwarddetermined woman gazing upward
How to Be Perennial
Comprehensive biological assessments, expert longevity guidance, education and tracking
Measure
Assess your health at the molecular level, with conventional and emerging biomarkers that are the body's first indicators of change
Learn
Access to longevity researchers and specialists providing evidence-based information on breakthrough interventions and advancements
Track
Create trendlines of your biological data, hindsight analyses and predictive biological age estimates
Optimize
Longevity-focused, actionable program, developed by industry leading experts in the gerosciences, fitness, sleep, and nutrition
How to Be Perennial
Comprehensive biological assessments, expert longevity guidance, education and tracking
Measure
Assess your health at the molecular level, with standard and cutting-edge, blood-based biomarkers that are the body's first indicators of change
Learn
Access to longevity researchers and specialists providing evidence-based information on breakthrough interventions and advancements
Optimize
Longevity-focused, actionable program, developed by industry leading experts in the gerosciences, fitness, sleep, and nutrition
Track
Create trendlines of your biological data, hindsight analyses and predictive biological age estimates
JOIN THE WAITLIST

Approach

Our AI-native longevity platform employs powerful machine learning to quantify health longevity status, identify personalized interventions and predict their impact, and then track and optimize the entire healthy longevity management process.
Multiomic (e.g., epigenetics, metabolomics, proteomics, etc.) assessment of an individual's biologic aging journey.
Insights into key determinants of longevity allowing the platform's intelligence capabilities to identify personalized precision longevity interventions.
Predictive models that dynamically track and optimize the longevity management journey through multiple individualized biomarkers.
Dashboard mockup

Science and Technology

ORION

AI-driven multimodal, multiomic data structuring and analysis engine that extracts quantified cross-sectional and longitudinal insights across multiple dimensions health and wellness.
Mockup

POLARIS

Machine-learning analytics platform that creates personalized frameworks of longevity risks and opportunities and identifies specific interventions tailored to individual biology, scientific evidence and expected longevity impact.
Mockup

PEGASUS

Predictive, interactive AI suite purpose-built for longitudinal multiomic data using scenario analysis to optimize personalized precision longevity management plans.

Board of Directors

Chairman and Co-Founder

Founder and CEO of Cambrian Biopharma, pioneer and thought leader in the longevity space, founder of Apollo Ventures, the first global longevity-focused VC firm.

Director, CEO and Co-Founder

Former CEO of publicly traded biotech company Vaxart, 30+ years of experience in healthcare, technology, and finance, with roles from IBM to McKinsey to Wall Street.

Founder and CEO of Adore Me, a disruptive e-commerce company acquired by Victoria Secret for $400M in 2023.

CEO of Apeiron Investment Group, the investment firm of serial entrepreneur Christian Angermayer, oversees a portfolio of 130+ companies shaping the next human agenda.

Advisors

Leading longevity researcher, discovered several "longevity genes", founder Institute for Aging Research at Albert Einstein College of Medicine, professor of medicine and genetics, directs the Longevity Gene Project.

Pioneer in preventive precision medicine, applied genomics and quantified health and longevity, one of New York’s premiere concierge doctors, Fellow in the American College of Physicians and the American College of Preventive Medicine.

Serial entrepreneur, founded $2.5 bn Apeiron Investment Group to invest in companies shaping the next human agenda, including longevity ones - such as Rejuveron Life Sciences, Cambrian Biopharma, and Perennial AI.

Stanford University adjunct professor teaching machine learning and data science, researcher in the Dpt. of Biomedical Data Science at Stanford Medical School, co-founder of precision genetics company Galatea Bio

Executive Team

Director, CEO and Co-Founder

Former CEO of publicly traded biotech company Vaxart, 30+ years of experience in healthcare, technology, and finance, with roles from IBM to McKinsey to Wall Street.

Chief Scientific Officer

Published geroscientist, former Senior Research Scientist at the University of Washington Medical School, former manager of the Nathan Shock Center Invertebrate Healthspan and Longevity Core.

Chief Technology Officer

Technologist with deep experience in software development, machine learning, and data science, has built scalable systems for companies ranging from startups to large corporates such as Blackstone, GEP Worldwide, Chegg Inc.